Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 21442031)

1.

Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth.

Chun JY, Tummala R, Nadiminty N, Lou W, Liu C, Yang J, Evans CP, Zhou Q, Gao AC.

Genes Cancer. 2010 Aug;1(8):868-76. doi: 10.1177/1947601910383416.

2.

Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer.

Liu C, Nadiminty N, Tummala R, Chun JY, Lou W, Zhu Y, Sun M, Evans CP, Zhou Q, Gao AC.

Genes Cancer. 2011 Feb;2(2):151-9. doi: 10.1177/1947601911409744.

5.

Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells.

Xu D, Lin TH, Li S, Da J, Wen XQ, Ding J, Chang C, Yeh S.

Cancer Lett. 2012 Mar;316(1):11-22. doi: 10.1016/j.canlet.2011.10.006. Epub 2011 Oct 10.

6.

Adrenomedullin blockade suppresses growth of human hormone-independent prostate tumor xenograft in mice.

Berenguer-Daizé C, Boudouresque F, Bastide C, Tounsi A, Benyahia Z, Acunzo J, Dussault N, Delfino C, Baeza N, Daniel L, Cayol M, Rossi D, El Battari A, Bertin D, Mabrouk K, Martin PM, Ouafik L.

Clin Cancer Res. 2013 Nov 15;19(22):6138-50. doi: 10.1158/1078-0432.CCR-13-0691. Epub 2013 Oct 7.

7.

Andrographolide suppresses IL-6/Stat3 signaling in peripheral blood mononuclear cells from patients with chronic rhinosinusitis with nasal polyps.

Kou W, Sun R, Wei P, Yao HB, Zhang C, Tang XY, Hong SL.

Inflammation. 2014 Oct;37(5):1738-43. doi: 10.1007/s10753-014-9902-5.

PMID:
24803294
8.
9.

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .

Lou W, Ni Z, Dyer K, Tweardy DJ, Gao AC.

Prostate. 2000 Feb 15;42(3):239-42.

PMID:
10639195
11.

IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR.

Rojas A, Liu G, Coleman I, Nelson PS, Zhang M, Dash R, Fisher PB, Plymate SR, Wu JD.

Oncogene. 2011 May 19;30(20):2345-55. doi: 10.1038/onc.2010.605. Epub 2011 Jan 24.

12.

Andrographolide and analogues in cancer prevention.

Mishra SK, Tripathi S, Shukla A, Oh SH, Kim HM.

Front Biosci (Elite Ed). 2015 Jan 1;7:255-66.

PMID:
25553378
13.

Andrographolide inhibits the adhesion of gastric cancer cells to endothelial cells by blocking E-selectin expression.

Jiang CG, Li JB, Liu FR, Wu T, Yu M, Xu HM.

Anticancer Res. 2007 Jul-Aug;27(4B):2439-47.

14.

Compensatory upregulation of tyrosine kinase Etk/BMX in response to androgen deprivation promotes castration-resistant growth of prostate cancer cells.

Dai B, Chen H, Guo S, Yang X, Linn DE, Sun F, Li W, Guo Z, Xu K, Kim O, Kong X, Melamed J, Qiu S, Chen H, Qiu Y.

Cancer Res. 2010 Jul 1;70(13):5587-96. doi: 10.1158/0008-5472.CAN-09-4610. Epub 2010 Jun 22.

15.

Mitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographis paniculata.

Yang S, Evens AM, Prachand S, Singh AT, Bhalla S, David K, Gordon LI.

Clin Cancer Res. 2010 Oct 1;16(19):4755-68. doi: 10.1158/1078-0432.CCR-10-0883. Epub 2010 Aug 26.

17.

Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway.

Lee SO, Lou W, Hou M, Onate SA, Gao AC.

Oncogene. 2003 Sep 11;22(39):7981-8.

PMID:
12970746
18.

IL-6/IL-6R as a potential key signaling pathway in prostate cancer development.

Azevedo A, Cunha V, Teixeira AL, Medeiros R.

World J Clin Oncol. 2011 Dec 10;2(12):384-96. doi: 10.5306/wjco.v2.i12.384.

19.

Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.

Culig Z, Bartsch G, Hobisch A.

Mol Cell Endocrinol. 2002 Nov 29;197(1-2):231-8. Review.

PMID:
12431817
20.

Proinflammatory cytokine interleukin-6 in prostate carcinogenesis.

Culig Z.

Am J Clin Exp Urol. 2014 Oct 2;2(3):231-8. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk